Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Mobia Medical, Inc.MOBI · Entity 5669 | Chief Financial Officer | February 23, 2026 | June 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Mobia Medical, Inc.
Report date February 23, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Exceller Hunt Microtransponder 2017, LP | 560,068 |
Reported balance
After 2026-02-23 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-02-23 · Other · Disposed 249,750 · Balance 560,068 F1: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering and is reported pursuant to Rule 16a-2(a). F2: Prior to the Issuer's initial public offering on May 7, 2026, the Curnes Fund 2001 and the Exceller Hunt Microtransponder 2017, LP distributed 175,077 and 249,750 shares of the Issuer's common stock, respectively, to their members (the "Distributions"). The Reporting Person received 58,359 shares of common stock in the Distributions. The Reporting Person's prior Form 3, dated May 7, 2026 and Form 4, dated May 11, 2026, inadvertently reported ownership prior to the Distributions. This Form 4 has been updated to reflect the Reporting Person's ownership following the Distributions. All shares in the Distributions remain subject to the lock-up restrictions implemented in connection with the initial public offering. |
| Common StockSEC Table I · non-derivative | IndirectBy Curnes Fund 2001 | 0 |
Reported balance
After 2026-02-23 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-02-23 · Other · Disposed 175,077 · Balance 0 F1: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering and is reported pursuant to Rule 16a-2(a). F2: Prior to the Issuer's initial public offering on May 7, 2026, the Curnes Fund 2001 and the Exceller Hunt Microtransponder 2017, LP distributed 175,077 and 249,750 shares of the Issuer's common stock, respectively, to their members (the "Distributions"). The Reporting Person received 58,359 shares of common stock in the Distributions. The Reporting Person's prior Form 3, dated May 7, 2026 and Form 4, dated May 11, 2026, inadvertently reported ownership prior to the Distributions. This Form 4 has been updated to reflect the Reporting Person's ownership following the Distributions. All shares in the Distributions remain subject to the lock-up restrictions implemented in connection with the initial public offering. |
| Common StockSEC Table I · non-derivative | Direct | 366,997 |
Reported balance
After 2026-06-09 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-06-09 · Purchase · Acquired 5,000 · Balance 366,997 F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.65 to $13.01. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above. F4: Includes 58,359 shares acquired in a pro rata distribution in kind, which was exempt from reporting pursuant to Rule 16a-13. |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trusts | 5,742 |
Reported balance
Holding disclosure · report date 2026-02-23 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 5,742 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering and is reported pursuant to Rule 16a-2(a).
F2: Prior to the Issuer's initial public offering on May 7, 2026, the Curnes Fund 2001 and the Exceller Hunt Microtransponder 2017, LP distributed 175,077 and 249,750 shares of the Issuer's common stock, respectively, to their members (the "Distributions"). The Reporting Person received 58,359 shares of common stock in the Distributions. The Reporting Person's prior Form 3, dated May 7, 2026 and Form 4, dated May 11, 2026, inadvertently reported ownership prior to the Distributions. This Form 4 has been updated to reflect the Reporting Person's ownership following the Distributions. All shares in the Distributions remain subject to the lock-up restrictions implemented in connection with the initial public offering.
F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.65 to $13.01. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.
F4: Includes 58,359 shares acquired in a pro rata distribution in kind, which was exempt from reporting pursuant to Rule 16a-13.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2026 Filed Jun 11, 2026 23:10 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | PurchaseCommon Stock | 5,000 | $12.79 | $63,969.00 |
DisclosureSEC source: 0001193125-26-268109 · ownership.xml · nonDerivative · entry 3 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 366,997 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.65 to $13.01. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above. F4 · balance_after: Includes 58,359 shares acquired in a pro rata distribution in kind, which was exempt from reporting pursuant to Rule 16a-13. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionConvertible Notes · Derivative | 4,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 25 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP Disclosed balance after: 0 Underlying: Common Stock · 333,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F2 · price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F2 · derivative.exercise_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F2 · derivative.expiration_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionConvertible Notes · Derivative | 2,100,937.62 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 24 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Curnes Fund 2001 Disclosed balance after: 0 Underlying: Common Stock · 175,077 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F2 · price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F2 · derivative.exercise_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F2 · derivative.expiration_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | OtherWarrants · Derivative | 24,000 | Not disclosed Strike: $14.65 | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 23 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,794 shares Expires 2033-05-24 F5 · price: The warrants are currently exercisable. In connection with the Offering, the warrants were exercised according to the terms of the applicable warrant agreement. The warrants have a net exercise provision under which the Reporting Person may, in lieu of payment of the exercise price in cash, surrender the warrants and receive a net amount of shares based on the fair market value of the shares at the time of exercise of the warrants after deduction of the aggregate exercise price. F5 · derivative.exercise_date: The warrants are currently exercisable. In connection with the Offering, the warrants were exercised according to the terms of the applicable warrant agreement. The warrants have a net exercise provision under which the Reporting Person may, in lieu of payment of the exercise price in cash, surrender the warrants and receive a net amount of shares based on the fair market value of the shares at the time of exercise of the warrants after deduction of the aggregate exercise price. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | OtherWarrants · Derivative | 23,666 | Not disclosed Strike: $14.65 | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 22 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,890 shares Expires 2033-06-13 F5 · price: The warrants are currently exercisable. In connection with the Offering, the warrants were exercised according to the terms of the applicable warrant agreement. The warrants have a net exercise provision under which the Reporting Person may, in lieu of payment of the exercise price in cash, surrender the warrants and receive a net amount of shares based on the fair market value of the shares at the time of exercise of the warrants after deduction of the aggregate exercise price. F5 · derivative.exercise_date: The warrants are currently exercisable. In connection with the Offering, the warrants were exercised according to the terms of the applicable warrant agreement. The warrants have a net exercise provision under which the Reporting Person may, in lieu of payment of the exercise price in cash, surrender the warrants and receive a net amount of shares based on the fair market value of the shares at the time of exercise of the warrants after deduction of the aggregate exercise price. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionSeries F Preferred Stock · Derivative | 285,846 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 21 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP Disclosed balance after: 0 Underlying: Common Stock · 82,068 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionSeries E-2 Preferred Stock · Derivative | 596,219 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 20 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP Disclosed balance after: 0 Underlying: Common Stock · 171,179 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionSeries E-1 Preferred Stock · Derivative | 272,271 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 19 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP Disclosed balance after: 0 Underlying: Common Stock · 78,171 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionSeries D Preferred Stock · Derivative | 505,269 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 18 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP Disclosed balance after: 0 Underlying: Common Stock · 145,067 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionSeries C Preferred Stock · Derivative | 20,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 17 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trusts Disclosed balance after: 0 Underlying: Common Stock · 5,742 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionSeries F Preferred Stock · Derivative | 284,986 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 16 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 81,821 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionSeries E-1 Preferred Stock · Derivative | 29,168 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 15 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,374 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionSeries D Preferred Stock · Derivative | 383,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 14 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 110,058 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionSeries C Preferred Stock · Derivative | 100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 13 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,710 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionSeries A Preferred Stock · Derivative | 191,330 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 12 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,932 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.exercise_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. F1 · derivative.expiration_date: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionCommon Stock | 175,077 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · nonDerivative · entry 7 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Curnes Fund 2001 Disclosed balance after: 175,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionCommon Stock | 333,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · nonDerivative · entry 6 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP Disclosed balance after: 809,818 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionCommon Stock | 476,485 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · nonDerivative · entry 5 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP Disclosed balance after: 476,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionCommon Stock | 5,742 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · nonDerivative · entry 4 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trusts Disclosed balance after: 5,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | Tax withholdingCommon Stock | 13,368 | $15.00 | $200,520.00 |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · nonDerivative · entry 3 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,638 Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | OtherCommon Stock | 13,684 | $14.65 | $200,511.65 |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · nonDerivative · entry 2 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,006 Read SEC document |
| May 11, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | ConversionCommon Stock | 283,895 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · nonDerivative · entry 1 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock converted into Common Stock immediately prior to the completion of the Issuer's initial public offering (the "Offering") pursuant to its terms. Read SEC document |
| May 07, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | GrantStock Option · Derivative | 206,070 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 11 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,070 Underlying: Common Stock · 206,070 shares Expires 2036-05-07 F4 · derivative.exercise_date: The stock option will vest as to 25% of the underlying shares on May 7, 2027, and will vest thereafter in 36 substantially equal monthly installments. Read SEC document |
| February 23, 2026 Filed Jun 11, 2026 23:10 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | OtherCommon Stock | 175,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-268109 · ownership.xml · nonDerivative · entry 2 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Curnes Fund 2001 Disclosed balance after: 0 F1 · date: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering and is reported pursuant to Rule 16a-2(a). F2 · kind: Prior to the Issuer's initial public offering on May 7, 2026, the Curnes Fund 2001 and the Exceller Hunt Microtransponder 2017, LP distributed 175,077 and 249,750 shares of the Issuer's common stock, respectively, to their members (the "Distributions"). The Reporting Person received 58,359 shares of common stock in the Distributions. The Reporting Person's prior Form 3, dated May 7, 2026 and Form 4, dated May 11, 2026, inadvertently reported ownership prior to the Distributions. This Form 4 has been updated to reflect the Reporting Person's ownership following the Distributions. All shares in the Distributions remain subject to the lock-up restrictions implemented in connection with the initial public offering. Read SEC document |
| February 23, 2026 Filed Jun 11, 2026 23:10 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | OtherCommon Stock | 249,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-268109 · ownership.xml · nonDerivative · entry 1 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP Disclosed balance after: 560,068 F1 · date: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Issuer's initial public offering and is reported pursuant to Rule 16a-2(a). F2 · kind: Prior to the Issuer's initial public offering on May 7, 2026, the Curnes Fund 2001 and the Exceller Hunt Microtransponder 2017, LP distributed 175,077 and 249,750 shares of the Issuer's common stock, respectively, to their members (the "Distributions"). The Reporting Person received 58,359 shares of common stock in the Distributions. The Reporting Person's prior Form 3, dated May 7, 2026 and Form 4, dated May 11, 2026, inadvertently reported ownership prior to the Distributions. This Form 4 has been updated to reflect the Reporting Person's ownership following the Distributions. All shares in the Distributions remain subject to the lock-up restrictions implemented in connection with the initial public offering. Read SEC document |
| February 05, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | GrantConvertible Notes · Derivative | 100,937.62 | $100,937.62 | $10,188,403,131.26 |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 10 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Curnes Fund 2001 Disclosed balance after: 2,100,937.62 Underlying: Common Stock · 8,411 shares Expires not disclosed F2 · derivative.exercise_price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F3 · date: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Offering, and is reported herein pursuant to Rule 16a-2(a). F2 · derivative.exercise_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F2 · derivative.expiration_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. Read SEC document |
| January 30, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | GrantConvertible Notes · Derivative | 4,000,000 | $4,000,000.00 | $16,000,000,000,000.00 |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 9 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Exceller Hunt Microtransponder 2017, LP Disclosed balance after: 4,000,000 Underlying: Common Stock · 333,333 shares Expires not disclosed F2 · derivative.exercise_price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F3 · date: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Offering, and is reported herein pursuant to Rule 16a-2(a). F2 · derivative.exercise_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F2 · derivative.expiration_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. Read SEC document |
| January 30, 2026 Filed May 12, 2026 01:36 UTC | Mobia Medical, Inc. MOBI · Entity 5669 | GrantConvertible Notes · Derivative | 2,000,000 | $2,000,000.00 | $4,000,000,000,000.00 |
DisclosureSEC source: 0001628280-26-033804 · wk-form4_1778549766.xml · derivative · entry 8 Curnes Nelson Bunker · CIK 0002124944 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Curnes Fund 2001 Disclosed balance after: 2,000,000 Underlying: Common Stock · 166,666 shares Expires not disclosed F2 · derivative.exercise_price: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F3 · date: This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Offering, and is reported herein pursuant to Rule 16a-2(a). F2 · derivative.exercise_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. F2 · derivative.expiration_date: The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.